Literature DB >> 6352136

Radiation therapy in the management of ovarian cancer.

A J Dembo.   

Abstract

The present review of selected clinical trials of the use of radiotherapy in ovarian cancer indicates that this modality has a curative role in postoperative treatment. Techniques which encompass the entire peritoneal cavity produce superior survival rates and better control of occult upper abdominal metastasis than the techniques which treat only part of the peritoneum. The volume of residual tumour, its pathology subtype and grade, and the presenting stage each independently influence the outcome of therapy. An approach to planning treatment which considers all of these variables is presented. No long-term survival data exist to permit a comparison of the relative efficacies of abdominopelvic irradiation and cisplatin-based combination chemotherapy regimes, but a rational strategy for choice of treatment can be devised. Combined modality therapy is an important area for future study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352136

Source DB:  PubMed          Journal:  Clin Obstet Gynaecol        ISSN: 0306-3356


  1 in total

Review 1.  Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer.

Authors:  Dmitri Pchejetski; Albandri Alfraidi; Keith Sacco; Heba Alshaker; Aun Muhammad; Leonardo Monzon
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-11       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.